Interview with LGM Pharma’s CEO, Prasad Raje
BOCA RATON, Fla.--(BUSINESS WIRE)--LGM Pharma today announced that it has acquired the formulation development and drug product contract manufacturing business of Nexgen Pharma, Inc. The combination brings together LGM Pharma’s global leadership in Active Pharmaceutical Ingredient (API) sourcing, distribution and supply chain management with Nexgen Pharma’s comprehensive drug product contract development and manufacturing (CDMO) services. The combined firm, which will continue to be known as LGM Pharma, has all the capabilities needed to help pharmaceutical and biotechnology customers accelerate and optimize the new product pathway, from early R&D and clinical development through manufacturing, regulatory submission, commercialization and distribution.
XGen Pharmaceuticals DJB, Inc. Announces New President
Nexgen Pharma`s Generic Ursodiol Receives Approval in US
LGM Pharma, a contract development and manufacturing organization (CDMO) located in Erlanger, KY, announced on July 27, 2020 that it has acquired Nexgen Pharma, a drug product contract manufacturing company headquartered in Irvine, CA.
Nexgen Pharma 's Generic Acetaminophen; Butalbital; Caffeine ReceivesApproval in US